Company / FCF Margin
Anixa Biosciences Inc FCF Margin History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-967.5%
FY2022
5-year range
-1966.8% / -387.6%
FY2018-FY2022
Trend
+50.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 7 years, ranging from -1966.8% in FY2020 to 14.1% in FY2016.
Based on SEC 10-K filings.
-967.5% in FY2022 with a 5-year CAGR of +208.5%.
Declined from -387.6% to -967.5% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -580.0pp
- 5-Year Change
- +208.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, fcf margin increased 50.8% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -967.5% | +50.8% |
| FY2020 | -1966.8% | -407.4% |
| FY2019 | -387.6% | +63.3% |
| FY2018 | -1055.7% | +10.2% |
| FY2017 | -1176.1% | -8417.3% |
| FY2016 | 14.1% | +121.7% |
| FY2015 | -65.1% | - |
| FY2014 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026